M&A Deal Summary |
|
|---|---|
| Date | 2024-03-12 |
| Target | Plymouth Rubber Group |
| Sector | Manufacturing |
| Buyer(s) | Talde Private Equity |
| Sellers(s) | Versa Capital Management |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1976 |
| PE ASSETS | 170M EUR |
| Size | Small |
| Type | Sector Agnostic |
Talde Private Equity is a private equity firm that targets investments in small to medium-sized businesses throughout Spain. The Firm seeks companies with €15 to €70 million where it can commit €5 to €15 million for growth initiatives or opportunities for consolidation. Talde does not have any sector preferences however, the Firm will not invest in real estate or provide project financing. Talde Private Equity was formed in 1976 and is headquartered in Bilbao, Spain.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector (Manufacturing) | 3 of 3 |
| Type (Secondary Buyout) | 1 of 1 |
| Country (Spain) | 8 of 8 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-13 |
AJL Ophthalmic
Alava, Spain AJL Ophthalmic is a manufacturer of medical products ranging from ophthalmology, airflow, and craniofacial reconstruction to veterinary equipment and accessories. AJL Ophthalmic was founded in 1992 and is based in Alava, Spain. |
Buy | - |
| Category | Distressed Investor |
|---|---|
| Founded | 2004 |
| PE ASSETS | 1.4B USD |
| Size | Large |
| Type | Sector Agnostic |
Versa Capital Management is a private equity firm focused on investing in complex or distressed situations. Versa will consider businesses headquartered in North America and valued between $100 million and $1 billion. Prospective investment situations include buyouts, divestitures, recapitalizations, restructurings/turnarounds, take privates, rescue financings, and liquidations. Versa Capital Management is headquartered in Philadelphia, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 25 of 25 |
| Sector (Manufacturing) | 3 of 3 |
| Type (Secondary Buyout) | 4 of 4 |
| Country (Spain) | 1 of 1 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-30 |
SynCardia Systems
Tucson, Arizona, United States SynCardia Systems is a medical technology company focused on developing, manufacturing and marketing the SynCardia Total Artificial Heart, an implantable system designed to assume the full function of a failed human heart in patients suffering from end-stage biventricular (both sides) heart failure. SynCardia Systems is based in Tucson, Arizona. |
Sell | - |
